Ethnicity, genomic ancestry, and HBV genotype in off-treatment outcomes following nucleos(t)ide analogue cessation : a prospective multicentre trial (COIN-B)
Source
Nature communications - ISSN 2041-1723- (2026) p. 1-13
Immune control, HBsAg loss or flare requiring liver transplant-diverse outcomes after stopping NUC therapy
Source
Viruses - ISSN 1999-4915-18:9 (2026) p.
Towards a finite future : characterisation of the burden of Hepatitis B and D in Belgium and individualisation of Nucleos(t)ide Analogue Cessation
Source
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences, 2026,270 p.
Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis : insights from a multicenter European cohort
Source
JHEP Reports - ISSN 2589-5559-8:8 (2026) p.
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis 6-follow-up from the RETRACT-6 cohort
Source
Journal of hepatology - ISSN 0168-8278-85:1 (2026) p. 61-70